Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Cellares and Sony Announce a Joint Development Collaboration to Integrate Flow Cytometry-Based Sorting and Online Analysis into an Automated, High-Throughput Cell Therapy Manufacturing Platform

    Sep 13, 2024, 08:44 AM by
    Cellares and Sony have announced a collaboration to integrate Sony’s flow cytometry-based sorting technology into Cellares' automated Cell Shuttle platform for cell therapy manufacturing. This integration will enhance automation, scalability, and real-time monitoring, improving the efficiency of sorting-dependent therapies like Treg and HSC. It aims to streamline the manufacturing process and reduce costs.
    Full story
  • Opentrons introduces Flex Prep: A no-code robot offering the simplicity of a pipette with the versatility of a liquid handler

    Sep 13, 2024, 08:44 AM by
    Opentrons introduces Flex Prep, a no-code robot combining the simplicity of a pipette with the versatility of a liquid handler. Its intuitive touchscreen allows scientists to program pipetting tasks in under a minute. Flex Prep enhances lab automation, offering affordable and versatile capabilities for both basic and complex protocols, empowering researchers to automate tasks without prior robotics experience.
    Full story
  • Cleveland Diagnostics’ Prostate Cancer Awareness Campaign ‘A PSA on PSA’ Returns This September

    Sep 12, 2024, 07:12 AM by
    National Initiative to Increase Education & Awareness; Raise Funds for ZERO Prostate Cancer with Donation Made for Every Patient Discussion Guide Downloaded at PSAonPSA.com
    Full story
  • Breakthrough towards protein sequencing using Oxford Nanopore holds promise for disease research and drug development

    Sep 12, 2024, 07:12 AM by
    In a research collaboration with Oxford Nanopore Technologies, scientists from the University of Washington have unveiled a groundbreaking ‘proof-of-concept’ method for reading single protein molecules
    Full story
  • GenNext and Agilent Unveil Groundbreaking Technology Integration to Accelerate High-Value Decision Making in Biopharmaceutical Research

    Sep 12, 2024, 07:12 AM by
    GenNext Technologies has announced a pioneering collaboration with Agilent, that promises to transform structural biology research for biopharmaceutical companies.
    Full story
  • ‘Dancing Molecules’ Could Be the Key to Cartilage Regeneration

    Sep 12, 2024, 01:00 AM by User Not Found
    Bio-IT World | Osteoarthritis affects more than 528 million people around the world. Cartilage in joints wears down, and bones rub against each other, causing pain, stiffness, and mobility issues. Current treatments slow down cartilage degeneration, though patients inevitably need expensive joint replacement surgery. However, researchers at Northwestern University discovered “dancing molecules” that might be the key to the first cartilage regenerative therapy.
    Full story
  • PathAI Launches MET Predict on AISight to Enhance NSCLC Assessments

    Sep 11, 2024, 09:32 AM by
    PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced the launch of MET Predict† on the AISightⓇ† Image management system (IMS). MET Predict is an AI-powered algorithm designed to help pathologists identify non-small cell lung cancer (NSCLC) tumors that may be more likely to have MET exon 14 skipping (METex14) or MET amplification, directly from an H&E whole slide image.
    Full story
  • PharmaForceIQ Announces Majority Investment by Eir Partners to Support and Accelerate Growth

    Sep 11, 2024, 09:32 AM by
    PharmaForceIQ Announces Majority Investment by Eir Partners to Support and Accelerate Growth Miami, FL – 10th September 2024, PharmaForceIQ (PFIQ), the leading end to end Omnichannel Solution for Pharmaceutical Marketing, Medical and Clinical teams today announced a significant investment by Eir Partners (Eir) to accelerate adoption of the company’s unique technology platform and services for the Life Science industry.
    Full story
  • Quotient Sciences and Vasa Therapeutics Announce Dosing of First Subjects with VS-041, a Novel Heart Failure Treatment

    Sep 11, 2024, 09:32 AM by
    Full story
  • Verisense Health Introduces an iOS App for its Smart Watch

    Sep 11, 2024, 09:32 AM by
    The Verisense Smart Watch, Which Collects Digital Health Data During Clinical Trials, is Now Compatible with Both Apple and Android Smartphones.
    Full story
  • Envision Pharma Group launches EnvisionOne Insights: A unified data and analytics solution for medical affairs

    Sep 11, 2024, 09:32 AM by
    One of the world’s leading technology solutions companies Envision Pharma Group has launched “EnvisionOne Insights” an innovative medical technology solution for the power of big dat
    Full story
  • AI and Biotechnology: Navigating Opportunities and Risks in the Bioeconomy

    Sep 11, 2024, 01:00 AM by User Not Found
    Bio-IT World | Last month’s Bioprocessing Venture, Innovation, and Partnering Conference brought together thought leaders from across the bioeconomy to discuss the rapidly evolving landscape of artificial intelligence (AI) in biotechnology.
    Full story
  • Researchers Add ‘New Piece to the Puzzle’ That is Celiac Disease

    Sep 10, 2024, 01:00 AM by User Not Found
    Bio-IT World | Celiac disease is a surprisingly common but substantially underdiagnosed autoimmune disorder estimated to affect 1 in 100 people globally. Left untreated, it can have “serious clinical consequences” for patients, including malnutrition, bone weakening, and potentially even a higher risk of certain cancers.
    Full story
  • APL and CurifyLabs partnership to support critically ill patients with 3D printing medicine technology

    Sep 6, 2024, 09:05 AM by
    Full story
  • Integrated DNA Technologies Bolsters Comprehensive Genomic Profiling Solutions with Launch of New Archer™ HRD Technology for Cancer Research

    Sep 6, 2024, 09:05 AM by
    Full story
  • Life Sciences Organizations Gain New Real-World Data Offering To Bring Precision Therapies And Diagnostics To Patients

    Sep 6, 2024, 09:05 AM by
    Proscia customers can leverage over 10 million de-identified pathology images alongside corresponding clinical and genomic data
    Full story
  • Andrew MacGarvey & Conditor Capital Launch Coronado Research to maximise the use of data and technology in drug development; Dr Nicholas Edwards announced as Chair

    Sep 6, 2024, 09:05 AM by
    Andrew MacGarvey & Conditor Capital Launch Coronado Research to maximise the use of data and technology in drug development; Dr Nicholas Edwards announced as Chair
    Full story
  • Global CDMO brings technological advancements & significant capacity to Ocean County, NJ location

    Sep 6, 2024, 09:05 AM by
    Full story
  • SPT Labtech and Synthace partner to accelerate drug discovery through accessible DOE

    Sep 6, 2024, 09:05 AM by
    Full story
  • Medical University of Graz Selects the HALO AP® Digital Pathology Platform to Deliver Comprehensive Diagnostics

    Sep 6, 2024, 09:05 AM by
    Indica Labs has announced the Diagnostics & Research Institute for Pathology at the Medical University of Graz has selected the HALO AP® digital pathology platform from Indica Labs to deliver primary diagnostics, alongside Aperio GT 450 scanners from Leica Biosystems.
    Full story
  • «
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27 (current)
  • 28
  • 29
  • 30
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy